Effects of Cyclen and Cyclam on Zinc(II)- and Copper(II)-Induced Amyloid β-Peptide Aggregation and Neurotoxicity

被引：104

作者：

Chen, Tingting ^{[2
,3
]}

Wang, Xiaoyong ^{[1
]}

He, Yafeng ^{[2
]}

Zhang, Changli ^{[2
]}

Wu, Ziyi ^{[2
]}

Liao, Kuo ^{[2
]}

Wang, Jianjun ^{[4
]}

Guo, Zijian ^{[2
]}

机构：

[1] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Peoples R China

[2] Nanjing Univ, Sch Chem & Chem Engn, State Key Lab Coordinat Chem, Nanjing 210093, Peoples R China

[3] Nantong Univ, Sch Chem & Chem Engn, Nantong 226019, Peoples R China

[4] Wayne State Univ, Sch Med, Detroit, MI 48202 USA

来源：

INORGANIC CHEMISTRY | 2009年 / 48卷 / 13期

关键词：

MACROCYCLIC TETRA-AMINES; ALZHEIMER A-BETA; METAL-IONS; NEURODEGENERATIVE DISEASES; MOLECULAR-MECHANISMS; PARKINSONS-DISEASES; HYDROGEN-PEROXIDE; TRANSGENIC MICE; CLEAVAGE AGENTS; SENILE PLAQUES;

D O I：

10.1021/ic900025x

中图分类号：

O61 [无机化学];

学科分类号：

070301 ; 081704 ;

摘要：

Amyloid beta-peptide (A beta) aggregation is highly associated with Alzheimer's disease, which is facilitated by Zn2+ and Cu2+. Macrocyclic polyamine chelators cyclen and cyclam, can effectively protect A beta against precipitation induced by Cu2+ or Zn2+; the production of H2O2 mediated by Cu-A beta can also be inhibited by these chelators.

引用

页码：5801 / 5809

页数：9

共 59 条

[41] Metalloenzyme-like activity of Alzheimer's disease β-amyloid -: Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H2O2 [J].

Opazo, C ;

Huang, XD ;

Cherny, RA ;

Moir, RD ;

Roher, AE ;

White, AR ;

Cappai, R ;

Masters, CL ;

Tanzi, RE ;

Inestrosa, NC ;

Bush, AI .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (43) :40302-40308

[42] Anti-viral cyclam macrocycles: rapid zinc uptake at physiological pH [J].

Paisey, SJ ;

Sadler, PJ .

CHEMICAL COMMUNICATIONS, 2004, (03) :306-307

[43] ENHANCED ELIMINATION OF CU-64 IN RATS BY CYCLEN, A MACROCYCLIC POLYAMINE [J].

PILICHOWSKI, JF ;

MICHELOT, J ;

BOREL, M ;

MEYNIEL, G .

NATURWISSENSCHAFTEN, 1983, 70 (04) :201-202

[44] Why is the amyloid beta peptide of Alzheimer's disease neurotoxic? [J].

Rauk, Arvi .

DALTON TRANSACTIONS, 2008, (10) :1273-1282

[45] Influence of multiple metal ions on β-amyloid aggregation and dissociation on a solid surface [J].

Ryu, Jungki ;

Girigoswami, Koyeli ;

Ha, Chanki ;

Ku, Sook Hee ;

Park, Chan Beum .

BIOCHEMISTRY, 2008, 47 (19) :5328-5335

[46] In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: A central role for bound transition metals [J].

Sayre, LM ;

Perry, G ;

Harris, PLR ;

Liu, YH ;

Schubert, KA ;

Smith, MA .

JOURNAL OF NEUROCHEMISTRY, 2000, 74 (01) :270-279

[47] Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases [J].

Selkoe, DJ .

NATURE CELL BIOLOGY, 2004, 6 (11) :1054-1061

[48] Copper-mediated amyloid-β toxicity is associated with an intermolecular histidine bridge [J].

Smith, David P. ;

Smith, Danielle G. ;

Curtain, Cyril C. ;

Boas, John F. ;

Pilbrow, John R. ;

Ciccotosto, Giuseppe D. ;

Lau, Tong-Lay ;

Tew, Deborah J. ;

Perez, Keyla ;

Wade, John D. ;

Bush, Ashley I. ;

Drew, Simon C. ;

Separovic, Frances ;

Masters, Colin L. ;

Cappai, Roberto ;

Barnham, Kevin J. .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (22) :15145-15154

[49] Alzheimer's and prion disease as disorders of protein conformation: implications for the design of novel therapeutic approaches [J].

Soto, C .

JOURNAL OF MOLECULAR MEDICINE-JMM, 1999, 77 (05) :412-418

[50] Protein misfolding and disease; protein refolding and therapy [J].

Soto, C .

FEBS LETTERS, 2001, 498 (2-3) :204-207

← 1 2 3 4 5 6 →